Among these, NNC0090-2746 and tirzepatide showed improved efficacy in terms of EE, insulin sensitivity and weight loss, as compared to single GLP-1R agonism in a model of diet-induced obesity [188, 189]. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.